Associate Professor, Dermatology, Stanford University Medical Center
Dermatology
Dr. David F. Fiorentino, MD
|
|
Give Review
David Fiorentino is an expert in the field of Dermatology. He studied medicine at Stanford University School of Medicine. Stanford University School of Medicine is one of the top medical schools in the US. Stanford University School of Medicine is ranked 2 in research and 25 in primary care medicine He received awards:"CMS Meaningful Use Stage 1 Certification" and "Fellow (FAAD)". David Fiorentino is also published. He has 35 publications published. The lastest publication: "Leukotriene B4 Activates Pulmonary Artery Adventitial Fibroblasts in Pulmonary Hypertension.' Doctor David F. Fiorentino, MD accepts Medicare payments and is listed with Medicare.gov.
Publications
- Leukotriene B4 Activates Pulmonary Artery Adventitial Fibroblasts in Pulmonary Hypertension.
- Dual mTOR Inhibition Is Required to Prevent TGF-β-Mediated Fibrosis: Implications for Scleroderma.
- Distinctive cutaneous and systemic features associated with antitranscriptional intermediary factor-1γ antibodies in adults with Dermatomyositis.
- Amyopathic Dermatomyositis: definitions, diagnosis, and management.
- Effect of the endothelin type A-selective endothelin receptor antagonist ambrisentan on digital Ulcers in patients with systemic sclerosis: Results of a prospective pi...
- Identification of Clinical Features and Autoantibodies Associated With Calcinosis in Dermatomyositis.
- Abstract 46: surgical treatment of systemic sclerosis: re-thinking the role and timing of peripheral sympathectomy.
- Atherosclerotic cardiovascular disease in hospitalized patients with systemic sclerosis: higher mortality than patients with lupus and rheumatoid arthritis.
- The plasma Cell signature in autoimmune disease.
- International consensus criteria for the diagnosis of Raynaud's phenomenon.
- A phase 1b clinical trial evaluating sifalimumab, an anti-IFN-? monoclonal antibody, shows target neutralisation of a type I IFN signature in blood of Dermatomyositis ...
- Molecular profiling to diagnose a case of atypical Dermatomyositis.
- Most Patients With Cancer-Associated Dermatomyositis Have Antibodies to Nuclear Matrix Protein NXP-2 or Transcription Intermediary Factor 1γ.
- Localized cutaneous fibrosing disorders.
- Atherosclerotic cardiovascular disease and Dermatomyositis: an analysis of the Nationwide Inpatient Sample survey.
- Skin disease in dermatomyositis.
- A Novel Dermato-Pulmonary Syndrome Associated With MDA-5 Antibodies: Report of 2 Cases and Review of the Literature.
- Consensus guidelines for the management of plaque Psoriasis.
- Pathogenesis of Dermatomyositis: role of cytokines and interferon.
- Endothelin Receptor Antagonists for the Treatment of Raynaud's Phenomenon and Digital Ulcers in Systemic Sclerosis.
- A pilot study of etanercept treatment for pemphigus vulgaris.
- Tyrosine kinases in inflammatory dermatologic disease.
- MQX-503, a novel formulation of nitroglycerin, improves the severity of Raynaud's phenomenon: a randomized, controlled trial.
- Molecular framework for response to imatinib mesylate in systemic sclerosis.
- Imatinib in the treatment of nephrogenic systemic fibrosis.
- Type I interferon in the induction or exacerbation of Dermatomyositis: what this observation tells us about the naturally occurring disease.
- Comparison of the reliability and validity of outcome instruments for cutaneous Dermatomyositis.
- Capillary regeneration in scleroderma: stem Cell therapy reverses phenotype?
- A pilot trial of rituximab in the treatment of patients with Dermatomyositis.
- The Yin and Yang of TNF-{alpha} inhibition.
- Update on cutaneous vasculitis.
- Successful use of rituximab for cutaneous vasculitis.
- Muir-Torre syndrome: confirmation of diagnosis by immunohistochemical analysis of cutaneous Lesions.
- Improvements in patient-reported outcomes with apremilast, an oral phosphodiesterase 4 inhibitor, in the treatment of moderate to severe Psoriasis: results from a phas...
Schools
Stanford University School Of Medicine
Stanford University Hospital
University Of Co School Of Med
Procedures Preformed
- Acne Surgery
- Destruction of Benign Skin Lesion
- Mohs Surgery
- Skin Tag Removal
Conditions Treated
- Acne
- Actinic Keratosis
- Athlete's Foot
- Atopic Dermatitis (Eczema)
- View All
Doctors Specialties
- Dermatology
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
- Fellow (FAAD)
Education
-
Stanford University -
University of Colorado -
Stanford University School of Medicine
Hospital
-
VA Palo Alto Health Care System -
Stanford Health Care
Drug Facts
| NPI NUMBER | 1740335025 | |
| NPPES Provider LastName | FIORENTINO | |
| NPPES Provider FirstName | DAVID | |
| NPPES Provider ZIPCode | 943042201 | |
| NPPES Provider State | CA | |
| Specialty Description | Dermatology | |
| Total Claim Count | 776.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1740335025 |
| Last Name Of The Provider | FIORENTINO |
| First Name Of The Provider | DAVID |
| View All |
Similar Doctors
|
|
Dr. Teresa Fu, MD |
|
Dr. Jennifer Boldrick, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Youn-Hee Kim, MD |
|
|
Dr. Anne Lynn S. Chang, MD |
|
|
Dr. Zakia Rahman, MD |
|
|
Dr. Kerri E. Rieger, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Lyle J. Rausch, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. David H. Peng, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jennifer K. Chen, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Richard O. Chen, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Laura L. Bernet, MD |
|
|
Dr. Oloruntoyin O. Falola, MD |
|
|
Dr. Aruna Venkatesan, MD |